Among patients with average life expectancies of less than 10 years, the proportion who underwent treatments such as surgery ...

After a comprehensive two-year follow-up, researchers found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality ...

The phase 2 CELLVX-230 trial is assessing the potential of FK-PC101 to prevent prostate cancer recurrence and delay ...

Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.

Overtreatment of prostate cancer is increasing in the United States among men with limited life expectancy, a new study ...

New London ― Dean Festa got lucky when he sought to make a change in his life insurance policy. His insurance agent told him ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments ...

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...

Early evidence suggests that stereotactic radiation therapy appears to be as effective, less onerous and less invasive than currently available treatment options. Prostate cancer that has spread ...